Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity.
CP: Immunology
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
27 06 2023
27 06 2023
Historique:
received:
15
11
2022
revised:
29
03
2023
accepted:
22
05
2023
medline:
4
10
2023
pubmed:
11
6
2023
entrez:
11
6
2023
Statut:
ppublish
Résumé
Certain serum proteins, including C-reactive protein (CRP) and D-dimer, have prognostic value in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nonetheless, these factors are non-specific, providing limited mechanistic insight into the peripheral blood mononuclear cell (PBMC) populations that drive the pathogenesis of severe COVID-19. To identify cellular phenotypes associated with disease, we performed a comprehensive, unbiased analysis of total and plasma-membrane PBMC proteomes from 40 unvaccinated individuals with SARS-CoV-2, spanning the whole disease spectrum. Combined with RNA sequencing (RNA-seq) and flow cytometry from the same donors, we define a comprehensive multi-omic profile for each severity level, revealing that immune-cell dysregulation progresses with increasing disease. The cell-surface proteins CEACAMs1, 6, and 8, CD177, CD63, and CD89 are strongly associated with severe COVID-19, corresponding to the emergence of atypical CD3
Identifiants
pubmed: 37302069
pii: S2211-1247(23)00624-1
doi: 10.1016/j.celrep.2023.112613
pmc: PMC10243220
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
112613Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U24 HG006673
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_19032
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W025647/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200871/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L019027
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N013433/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S036113/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1163/A21762
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S000081X/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT/204870/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T032413/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204845/Z/16/Z
Pays : United Kingdom
Organisme : Department of Health
ID : RG94028
Pays : United Kingdom
Organisme : Department of Health
ID : RG85445
Pays : United Kingdom
Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.